Nanotechnology in medicine uses materials engineered at a scale of roughly 1 to 100 nanometers, thousands of times smaller than a human hair, to deliver drugs more precisely, improve medical imaging, power new vaccines, and even build tiny surgical tools. The global nanomedicine market was valued at about $190 billion in 2023 and is projected to reach $410 billion by 2030, reflecting how quickly these applications are moving from lab to clinic.
Targeted Drug Delivery for Cancer
The most established use of medical nanotechnology is getting cancer drugs to tumors while sparing healthy tissue. Conventional chemotherapy floods the entire body, which is why side effects like nausea and hair loss are so common. Nanoparticle-based drugs take advantage of a quirk in tumor biology: tumors grow so fast that their blood vessels form with gaps and defects, making them far leakier than normal vessels. Nanoparticles are small enough to slip through those gaps but too large to pass through the tighter walls of healthy blood vessels. Once inside the tumor, the particles tend to stay put because tumors also lack effective drainage. This phenomenon, known as the enhanced permeability and retention effect, means the drug concentrates where it’s needed and largely avoids the rest of the body.
Several nanoparticle cancer drugs have been on the market for years. The first was a liposomal form of doxorubicin, approved by the FDA in 1995 for Kaposi’s sarcoma and later for ovarian cancer and multiple myeloma. A decade later, an albumin-bound form of paclitaxel was approved for breast, lung, and pancreatic cancers. More recent approvals include nanoparticle formulations of irinotecan for pancreatic and colorectal cancers (2015) and liposomal vincristine for acute lymphoid leukemia (2012). In each case, wrapping the drug in a nanoparticle shell reduced toxicity, improved how the drug circulated in the body, or both.
How Nanoparticles Power mRNA Vaccines
The COVID-19 pandemic brought one form of nanotechnology into billions of arms: lipid nanoparticles. mRNA vaccines work by delivering a genetic instruction set into your cells, which then produce a harmless piece of viral protein that trains the immune system. The problem is that bare mRNA is fragile. Enzymes in the body break it down almost immediately. Lipid nanoparticles solve this by wrapping the mRNA in a tiny sphere made of four types of fats.
The most critical of these are ionizable lipids. At the normal pH of your bloodstream, these lipids carry no electrical charge, which makes them compatible with the body and unlikely to damage cell membranes. But once immune cells swallow the nanoparticle and it lands inside an acidic compartment within the cell, the lipids pick up a positive charge. That charge shift destabilizes the compartment’s membrane, releasing the mRNA into the cell’s interior where it can be read and translated into protein. It’s an elegantly simple delivery trick: the nanoparticle stays inert until it reaches exactly the right environment, then activates. This same platform is now being adapted for vaccines against influenza, RSV, and several cancers.
Sharper Diagnostic Imaging
Nanoparticles are also changing how doctors see inside the body. Two types stand out: gold nanoparticles and quantum dots. Gold nanoparticles interact with light in unusual ways because of a property called surface plasmon resonance. When hit with specific wavelengths of light, they scatter and absorb it intensely, producing a strong signal that can enhance CT scans and other optical imaging techniques. Because gold is biologically inert, these particles can be coated with molecules that bind to specific cell types, essentially lighting up targets like cancer cells against a dark background.
Quantum dots are semiconductor crystals just a few nanometers across that glow in precise, tunable colors when excited by light. Their brightness and color stability far exceed traditional fluorescent dyes, making them useful for tracking individual cells, mapping tissue at high resolution, and detecting biomarkers at very low concentrations. Both technologies serve the same basic goal: giving clinicians contrast agents and sensors that are more sensitive and more specific than what came before.
Crossing the Blood-Brain Barrier
One of the toughest challenges in medicine is getting drugs into the brain. The blood-brain barrier is a tightly sealed layer of cells lining the brain’s blood vessels, designed to keep toxins and pathogens out. It also keeps out most medications, which is why conditions like Alzheimer’s, Parkinson’s, and brain tumors are so difficult to treat.
Researchers are engineering nanoparticles specifically to cross this barrier. One approach coats particles with surfactants that interact with receptors on the barrier’s surface, essentially hijacking the cell’s own transport machinery. Other strategies include attaching specific targeting molecules that trick the barrier into pulling the particle through, coating nanoparticles with cell membranes so they’re recognized as natural, or using external triggers like focused ultrasound to temporarily loosen the barrier and let particles slip in. None of these have reached widespread clinical use yet, but they represent some of the most active areas of nanomedicine research.
Rebuilding Tissue With Nanoscaffolds
Your body’s tissues are built on a meshwork of protein fibers called the extracellular matrix, which gives cells structural support and biochemical cues that guide their behavior. When bone or cartilage is badly damaged, the body often can’t rebuild this scaffolding on its own. Nanotechnology offers a workaround: three-dimensional nanofibrous scaffolds that mimic the structure of natural tissue at the nanometer scale.
These scaffolds are porous enough for cells to migrate into and are designed to gradually dissolve as the body replaces them with real tissue. For bone and cartilage repair, researchers have developed bilayer scaffolds where one layer mimics bone composition (using hydroxyapatite, the mineral found in natural bone) and the other mimics cartilage. The nanoscale fibers provide a surface texture that cells recognize and attach to more readily than they would to a smooth or larger-scale material. This approach is being tested for joint injuries, spinal fusion, and craniofacial reconstruction.
Micro and Nanorobots in Surgery
Perhaps the most futuristic application is the development of untethered micro and nanorobots designed to perform tasks inside the body. These are still experimental, but the proof-of-concept work is striking. Magnetically controlled microrobots have been injected into the eye of a living rabbit, steered wirelessly through the vitreous humor, and tracked with a camera, demonstrating the potential for delicate intraocular surgery without traditional instruments. Thermally responsive microgrippers, small enough to operate on individual cell clusters, have captured live cells from dense tissue inside capillary tubes.
On the more dramatic end, ultrasound-triggered “microbullets” made with biocompatible fuel can reach speeds over 6 meters per second, fast enough to penetrate deep tissue for targeted ablation or destruction of diseased cells. At the smallest scale, self-propelled nanotubes just 280 to 600 nanometers in diameter have drilled into and embedded themselves in single cells. These tools are years from clinical use, but they point toward a future where surgery could happen at a cellular level without a single incision.
Safety Concerns and Limitations
Working at the nanoscale introduces safety questions that don’t apply to larger materials. Size matters in unexpected ways: in animal studies, gold nanoparticles of 10 and 30 nanometers were able to cross into cell nuclei and cause DNA breaks, while 60-nanometer particles could not. The smaller particles also accumulated more heavily in the liver, kidneys, and intestines, while the larger ones concentrated in the spleen. Silver nanoparticles showed a similar pattern. Particles just 10 nanometers across caused tissue damage in the thymus, liver, and spleen of mice, while 60 and 100-nanometer particles of the same material did not.
The liver and kidneys bear the heaviest burden because they’re the organs responsible for filtering and clearing foreign substances. Oral exposure to certain nanoparticles has been linked to inflammation and damage in the intestinal tract and liver. These findings don’t mean approved nanomedicines are unsafe. Products like liposomal doxorubicin and albumin-bound paclitaxel have undergone extensive safety testing and have well-characterized side effect profiles. But they do mean that each new nanoparticle formulation requires careful evaluation, because changing the size, shape, or coating of a particle by even a few nanometers can fundamentally alter how the body handles it.